Cargando…
P922: ADJUSTED COMPARISONS OF CILTACABTAGENE AUTOLEUCEL WITH THERAPIES FROM REAL-WORLD CLINICAL PRACTICE: TWO-YEAR FOLLOW-UP ANALYSES FROM CARTITUDE-1 AND THE PROSPECTIVE LOCOMMOTION STUDY
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431099/ http://dx.doi.org/10.1097/01.HS9.0000970592.64148.2c |
| _version_ | 1785091119514648576 |
|---|---|
| author | Mateos, Maria-Victoria Weisel, Katja Martin, Tom Berdeja, Jesus Jakubowiak, Andrzej Stewart, Keith Jagannath, Sundar Lin, Yi Diels, Joris Ghilotti, Francesca Thilakarathne, Pushpike Perualila, Nolen Cabrieto, Jedelyn Erler-Yates, Nichola Jackson, Carolyn C Schecter, Jordan Strulev, Vadim Haddad, Imene Costa Filho, Octavio Pacaud, Lida Einsele, Hermann Moreau, Philippe |
| author_facet | Mateos, Maria-Victoria Weisel, Katja Martin, Tom Berdeja, Jesus Jakubowiak, Andrzej Stewart, Keith Jagannath, Sundar Lin, Yi Diels, Joris Ghilotti, Francesca Thilakarathne, Pushpike Perualila, Nolen Cabrieto, Jedelyn Erler-Yates, Nichola Jackson, Carolyn C Schecter, Jordan Strulev, Vadim Haddad, Imene Costa Filho, Octavio Pacaud, Lida Einsele, Hermann Moreau, Philippe |
| author_sort | Mateos, Maria-Victoria |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431099 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104310992023-08-17 P922: ADJUSTED COMPARISONS OF CILTACABTAGENE AUTOLEUCEL WITH THERAPIES FROM REAL-WORLD CLINICAL PRACTICE: TWO-YEAR FOLLOW-UP ANALYSES FROM CARTITUDE-1 AND THE PROSPECTIVE LOCOMMOTION STUDY Mateos, Maria-Victoria Weisel, Katja Martin, Tom Berdeja, Jesus Jakubowiak, Andrzej Stewart, Keith Jagannath, Sundar Lin, Yi Diels, Joris Ghilotti, Francesca Thilakarathne, Pushpike Perualila, Nolen Cabrieto, Jedelyn Erler-Yates, Nichola Jackson, Carolyn C Schecter, Jordan Strulev, Vadim Haddad, Imene Costa Filho, Octavio Pacaud, Lida Einsele, Hermann Moreau, Philippe Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431099/ http://dx.doi.org/10.1097/01.HS9.0000970592.64148.2c Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Mateos, Maria-Victoria Weisel, Katja Martin, Tom Berdeja, Jesus Jakubowiak, Andrzej Stewart, Keith Jagannath, Sundar Lin, Yi Diels, Joris Ghilotti, Francesca Thilakarathne, Pushpike Perualila, Nolen Cabrieto, Jedelyn Erler-Yates, Nichola Jackson, Carolyn C Schecter, Jordan Strulev, Vadim Haddad, Imene Costa Filho, Octavio Pacaud, Lida Einsele, Hermann Moreau, Philippe P922: ADJUSTED COMPARISONS OF CILTACABTAGENE AUTOLEUCEL WITH THERAPIES FROM REAL-WORLD CLINICAL PRACTICE: TWO-YEAR FOLLOW-UP ANALYSES FROM CARTITUDE-1 AND THE PROSPECTIVE LOCOMMOTION STUDY |
| title | P922: ADJUSTED COMPARISONS OF CILTACABTAGENE AUTOLEUCEL WITH THERAPIES FROM REAL-WORLD CLINICAL PRACTICE: TWO-YEAR FOLLOW-UP ANALYSES FROM CARTITUDE-1 AND THE PROSPECTIVE LOCOMMOTION STUDY |
| title_full | P922: ADJUSTED COMPARISONS OF CILTACABTAGENE AUTOLEUCEL WITH THERAPIES FROM REAL-WORLD CLINICAL PRACTICE: TWO-YEAR FOLLOW-UP ANALYSES FROM CARTITUDE-1 AND THE PROSPECTIVE LOCOMMOTION STUDY |
| title_fullStr | P922: ADJUSTED COMPARISONS OF CILTACABTAGENE AUTOLEUCEL WITH THERAPIES FROM REAL-WORLD CLINICAL PRACTICE: TWO-YEAR FOLLOW-UP ANALYSES FROM CARTITUDE-1 AND THE PROSPECTIVE LOCOMMOTION STUDY |
| title_full_unstemmed | P922: ADJUSTED COMPARISONS OF CILTACABTAGENE AUTOLEUCEL WITH THERAPIES FROM REAL-WORLD CLINICAL PRACTICE: TWO-YEAR FOLLOW-UP ANALYSES FROM CARTITUDE-1 AND THE PROSPECTIVE LOCOMMOTION STUDY |
| title_short | P922: ADJUSTED COMPARISONS OF CILTACABTAGENE AUTOLEUCEL WITH THERAPIES FROM REAL-WORLD CLINICAL PRACTICE: TWO-YEAR FOLLOW-UP ANALYSES FROM CARTITUDE-1 AND THE PROSPECTIVE LOCOMMOTION STUDY |
| title_sort | p922: adjusted comparisons of ciltacabtagene autoleucel with therapies from real-world clinical practice: two-year follow-up analyses from cartitude-1 and the prospective locommotion study |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431099/ http://dx.doi.org/10.1097/01.HS9.0000970592.64148.2c |
| work_keys_str_mv | AT mateosmariavictoria p922adjustedcomparisonsofciltacabtageneautoleucelwiththerapiesfromrealworldclinicalpracticetwoyearfollowupanalysesfromcartitude1andtheprospectivelocommotionstudy AT weiselkatja p922adjustedcomparisonsofciltacabtageneautoleucelwiththerapiesfromrealworldclinicalpracticetwoyearfollowupanalysesfromcartitude1andtheprospectivelocommotionstudy AT martintom p922adjustedcomparisonsofciltacabtageneautoleucelwiththerapiesfromrealworldclinicalpracticetwoyearfollowupanalysesfromcartitude1andtheprospectivelocommotionstudy AT berdejajesus p922adjustedcomparisonsofciltacabtageneautoleucelwiththerapiesfromrealworldclinicalpracticetwoyearfollowupanalysesfromcartitude1andtheprospectivelocommotionstudy AT jakubowiakandrzej p922adjustedcomparisonsofciltacabtageneautoleucelwiththerapiesfromrealworldclinicalpracticetwoyearfollowupanalysesfromcartitude1andtheprospectivelocommotionstudy AT stewartkeith p922adjustedcomparisonsofciltacabtageneautoleucelwiththerapiesfromrealworldclinicalpracticetwoyearfollowupanalysesfromcartitude1andtheprospectivelocommotionstudy AT jagannathsundar p922adjustedcomparisonsofciltacabtageneautoleucelwiththerapiesfromrealworldclinicalpracticetwoyearfollowupanalysesfromcartitude1andtheprospectivelocommotionstudy AT linyi p922adjustedcomparisonsofciltacabtageneautoleucelwiththerapiesfromrealworldclinicalpracticetwoyearfollowupanalysesfromcartitude1andtheprospectivelocommotionstudy AT dielsjoris p922adjustedcomparisonsofciltacabtageneautoleucelwiththerapiesfromrealworldclinicalpracticetwoyearfollowupanalysesfromcartitude1andtheprospectivelocommotionstudy AT ghilottifrancesca p922adjustedcomparisonsofciltacabtageneautoleucelwiththerapiesfromrealworldclinicalpracticetwoyearfollowupanalysesfromcartitude1andtheprospectivelocommotionstudy AT thilakarathnepushpike p922adjustedcomparisonsofciltacabtageneautoleucelwiththerapiesfromrealworldclinicalpracticetwoyearfollowupanalysesfromcartitude1andtheprospectivelocommotionstudy AT perualilanolen p922adjustedcomparisonsofciltacabtageneautoleucelwiththerapiesfromrealworldclinicalpracticetwoyearfollowupanalysesfromcartitude1andtheprospectivelocommotionstudy AT cabrietojedelyn p922adjustedcomparisonsofciltacabtageneautoleucelwiththerapiesfromrealworldclinicalpracticetwoyearfollowupanalysesfromcartitude1andtheprospectivelocommotionstudy AT erleryatesnichola p922adjustedcomparisonsofciltacabtageneautoleucelwiththerapiesfromrealworldclinicalpracticetwoyearfollowupanalysesfromcartitude1andtheprospectivelocommotionstudy AT jacksoncarolync p922adjustedcomparisonsofciltacabtageneautoleucelwiththerapiesfromrealworldclinicalpracticetwoyearfollowupanalysesfromcartitude1andtheprospectivelocommotionstudy AT schecterjordan p922adjustedcomparisonsofciltacabtageneautoleucelwiththerapiesfromrealworldclinicalpracticetwoyearfollowupanalysesfromcartitude1andtheprospectivelocommotionstudy AT strulevvadim p922adjustedcomparisonsofciltacabtageneautoleucelwiththerapiesfromrealworldclinicalpracticetwoyearfollowupanalysesfromcartitude1andtheprospectivelocommotionstudy AT haddadimene p922adjustedcomparisonsofciltacabtageneautoleucelwiththerapiesfromrealworldclinicalpracticetwoyearfollowupanalysesfromcartitude1andtheprospectivelocommotionstudy AT costafilhooctavio p922adjustedcomparisonsofciltacabtageneautoleucelwiththerapiesfromrealworldclinicalpracticetwoyearfollowupanalysesfromcartitude1andtheprospectivelocommotionstudy AT pacaudlida p922adjustedcomparisonsofciltacabtageneautoleucelwiththerapiesfromrealworldclinicalpracticetwoyearfollowupanalysesfromcartitude1andtheprospectivelocommotionstudy AT einselehermann p922adjustedcomparisonsofciltacabtageneautoleucelwiththerapiesfromrealworldclinicalpracticetwoyearfollowupanalysesfromcartitude1andtheprospectivelocommotionstudy AT moreauphilippe p922adjustedcomparisonsofciltacabtageneautoleucelwiththerapiesfromrealworldclinicalpracticetwoyearfollowupanalysesfromcartitude1andtheprospectivelocommotionstudy |